Roche Products Ltd
Supplier — contracts won
£2.8bnTotal value£2,810,959,981 across every award on file
5Awardspublished since 4 July 2024
Who buys from them
| Buyer | Awards | Value |
|---|---|---|
| NHS England | 5 | £2.8bn |
Every award on file
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 1 Jul 2025 | NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | NHS England | Biogen +20 | £986.3m |
| 31 May 2024 | NHS Framework - Blood Disorders including Haemophilia A and B - July 2024East Midlands | NHS England | Pfizer Ltd +8 | £765.0m |
| 25 Jul 2024 | NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024 | NHS England | Bayer Plc +8 | £416.8m |
| 22 Jul 2024 | NHS Branded Medicines Tranche Framework for London and South of EnglandEast Midlands | NHS England | Sun Pharma UK Ltd +28 | £381.0m |
| 25 Jun 2025 | NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National | NHS England | Roche Products Ltd +27 | £261.9m |
Organisations are grouped by name, because the notices carry no identifier that appears on all of them. A body that publishes under two spellings will appear twice; two different companies with the same trading name will appear as one. Check the individual notices before drawing a conclusion.